The cost to immunize during well-child visits

J Fontanesi1, M De Guire, K Holcomb

  • 1Partnership of Immunization Providers, Department of Pediatrics, University of California, 9500 Gilman Dr, MC 0927, La Jolla, CA 92093-0927, USA. jfontanesi@ucsd.edu

Insights

Immunizations during well-child visits incur opportunity costs for healthcare providers. Increased preventive care recommendations necessitate reevaluating visit times and clinic efficiency.

Area of Science:

  • Healthcare Management
  • Pediatric Primary Care
  • Health Economics

Background:

  • Ambulatory care settings face increasing demands for preventive services.
  • Immunization coverage rates are often low in underserved areas.
  • Patient-provider contact time has significantly increased.

Purpose of the Study:

  • To determine the incremental labor or opportunity costs of providing immunizations in ambulatory care.
  • To analyze the impact of immunizations on well-child visit duration.

Main Methods:

  • A time and motion analysis was conducted in 15 primary care practices (10 community clinics, 5 private practices).
  • Practices were located in Health Professional Shortage Areas.
  • Well-child visits with and without immunizations were compared based on duration.

Main Results:

  • Immunizations represent an opportunity cost during well-child visits.
  • Average patient-provider contact time was found to be longer than previously reported.
  • The duration of well-child visits varied depending on whether immunizations were administered.

Conclusions:

  • Increased immunization requirements impact the efficiency of primary care visits.
  • Current healthcare system parameters, including visit time and reimbursement rates, require reevaluation.
  • Optimizing clinic systems is crucial for meeting preventive care mandates.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...